Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Migraine

Free Subscription Articles published in Headache Retrieve available abstracts of 288 articles: HTML format Text format

Single Articles

August 2019
1. TOGHA M, Razeghi Jahromi S, Ghorbani Z, Martami F, et al
   Serum Vitamin B12 and Methylmalonic Acid Status in Migraineurs: A Case-Control Study.
   Headache. 2019 Aug 31. doi: 10.1111/head.13618.
   PubMed     Text format     Abstract available
   
   
   
2. SANDOE CH, Sasikumar S, Lay C, Lawler V, et al
   The Impact of Shift Work on Migraine: A Case Series and Narrative Review.
   Headache. 2019 Aug 30. doi: 10.1111/head.13622.
   PubMed     Text format     Abstract available
   
   
   
3. BUCH D, Chabriat H
   Lamotrigine in the Prevention of Migraine With Aura: A Narrative Review.
   Headache. 2019 Aug 29. doi: 10.1111/head.13615.
   PubMed     Text format     Abstract available
   
   
   
4. VERNIERI F, Paolucci M, Altamura C, Pasqualetti P, et al
   Onabotulinumtoxin-A in Chronic Migraine: Should Timing and Definition of Non-Responder Status Be Revised? Suggestions From a Real-Life Italian Multicenter Experience.
   Headache. 2019 Aug 27. doi: 10.1111/head.13617.
   PubMed     Text format     Abstract available
   
   
   
5. HAIGH SM, Chamanzar A, Grover P, Behrmann M, et al
   Cortical Hyper-Excitability in Migraine in Response to Chromatic Patterns.
   Headache. 2019 Aug 27. doi: 10.1111/head.13620.
   PubMed     Text format     Abstract available
   
   
   
6. HAJJARZADEH S, Nikniaz Z, Shalilahmadi D, Mahdavi R, et al
   Comparison of Diet Quality Between Women With Chronic and Episodic Migraine.
   Headache. 2019 Aug 27. doi: 10.1111/head.13623.
   PubMed     Text format     Abstract available
   
   
   
7. LIPTON RB, Munjal S, Buse DC, Alam A, et al
   Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study.
   Headache. 2019 Aug 13. doi: 10.1111/head.13588.
   PubMed     Text format     Abstract available
   
   
   
8. BUSE DC, Fanning KM, Reed ML, Murray S, et al
   Life With Migraine: Effects on Relationships, Career, and Finances From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
   Headache. 2019 Aug 12. doi: 10.1111/head.13613.
   PubMed     Text format     Abstract available
   
   
   
9. HAMMOND NG, Stinchcombe A
   Health Behaviors and Social Determinants of Migraine in a Canadian Population-Based Sample of Adults Aged 45-85 Years: Findings From the CLSA.
   Headache. 2019 Aug 2. doi: 10.1111/head.13610.
   PubMed     Text format     Abstract available
   
   
   July 2019
10. MCCLAIN IJ, Tsai MA, Guardia CF 3rd
    Prolonged Postictal Coma in Hemiplegic Migraine: A Case Report.
    Headache. 2019 Jul 24. doi: 10.1111/head.13606.
    PubMed     Text format    
    
    
    
11. BORKUM JM
    CGRP and Brain Functioning: Cautions for Migraine Treatment.
    Headache. 2019 Jul 21. doi: 10.1111/head.13591.
    PubMed     Text format     Abstract available
    
    
    
12. MATHEW PG, Klein BC
    Getting to the Heart of the Matter: Migraine, Triptans, DHE, Ditans, CGRP Antibodies, First/Second-Generation Gepants, and Cardiovascular Risk.
    Headache. 2019 Jul 18. doi: 10.1111/head.13601.
    PubMed     Text format     Abstract available
    
    
    
13. LAW EF, Powers SW, Blume H, Palermo TM, et al
    Screening Family and Psychosocial Risk in Pediatric Migraine and Tension-Type Headache: Validation of the Psychosocial Assessment Tool (PAT).
    Headache. 2019 Jul 18. doi: 10.1111/head.13599.
    PubMed     Text format     Abstract available
    
    
    
14. SPANOU I, Bougea A, Liakakis G, Rizonaki K, et al
    Relationship of Migraine and Tension-Type Headache With Hypothyroidism: A Literature Review.
    Headache. 2019 Jul 16. doi: 10.1111/head.13600.
    PubMed     Text format     Abstract available
    
    
    
15. KRYMCHANTOWSKI AV, Krymchantowski AG, Jevoux C
    Sodium Divalproate in Low Alternating Daily Doses for Migraine Prevention: A Retrospective Study.
    Headache. 2019 Jul 1. doi: 10.1111/head.13579.
    PubMed     Text format     Abstract available
    
    
    
16. BUSE DC, Greisman JD, Baigi K, Lipton RB, et al
    Migraine Progression: A Systematic Review. An Editorial Comment.
    Headache. 2019;59:974-976.
    PubMed     Text format    
    
    
    
17. YUAN H, Spare NM, Silberstein SD
    Targeting CGRP for the Prevention of Migraine and Cluster Headache: A Narrative Review.
    Headache. 2019;59 Suppl 2:20-32.
    PubMed     Text format     Abstract available
    
    
    
18. SCHWEDT TJ
    New and Emerging Treatments for the Acute and Preventive Therapy of Migraine and Other Headaches.
    Headache. 2019;59 Suppl 2:1-2.
    PubMed     Text format    
    
    
    
19. BERTELS Z, Pradhan AAA
    Emerging Treatment Targets for Migraine and Other Headaches.
    Headache. 2019;59 Suppl 2:50-65.
    PubMed     Text format     Abstract available
    
    
    
20. HALKER SINGH RB, Ailani J, Robbins MS
    Neuromodulation for the Acute and Preventive Therapy of Migraine and Cluster Headache.
    Headache. 2019;59 Suppl 2:33-49.
    PubMed     Text format     Abstract available
    
    
    
21. MORENO-AJONA D, Chan C, Villar-Martinez MD, Goadsby PJ, et al
    Targeting CGRP and 5-HT1F Receptors for the Acute Therapy of Migraine: A Literature Review.
    Headache. 2019;59 Suppl 2:3-19.
    PubMed     Text format     Abstract available
    
    
    June 2019
22. GELFAND AA, Buse DC, Cabana MD, Grimes B, et al
    The Association Between Parental Migraine and Infant Colic: A Cross-Sectional, Web-Based, U.S. Survey Study.
    Headache. 2019 Jun 20. doi: 10.1111/head.13575.
    PubMed     Text format     Abstract available
    
    
    
23. KAWATA AK, Hareendran A, Shaffer S, Mannix S, et al
    Evaluating the Psychometric Properties of the Migraine Functional Impact Questionnaire (MFIQ).
    Headache. 2019 Jun 5. doi: 10.1111/head.13569.
    PubMed     Text format     Abstract available
    
    
    
24. FARRIS SG, Burr EK, Abrantes AM, Thomas JG, et al
    Anxiety Sensitivity as a Risk Indicator for Anxiety, Depression, and Headache Severity in Women With Migraine.
    Headache. 2019 Jun 5. doi: 10.1111/head.13568.
    PubMed     Text format     Abstract available
    
    
    
25. HALL AL, Karvounides D, Gelfand AA, Mankin H, et al
    Improving the Patient Experience With Migraine Camp, a One-Day Group Intervention for Adolescents With Chronic Headache and Their Parents.
    Headache. 2019 Jun 5. doi: 10.1111/head.13570.
    PubMed     Text format     Abstract available
    
    
    
26. TEPPER SJ, Krege JH, Lombard L, Asafu-Adjei JK, et al
    Characterization of Dizziness After Lasmiditan Usage: Findings From the SAMURAI and SPARTAN Acute Migraine Treatment Randomized Trials.
    Headache. 2019 Jun 1. doi: 10.1111/head.13544.
    PubMed     Text format     Abstract available
    
    
    May 2019
27. ALAYDIN HC, Vuralli D, Keceli Y, Can E, et al
    Reduced Short-Latency Afferent Inhibition Indicates Impaired Sensorimotor Integrity During Migraine Attacks.
    Headache. 2019 May 20. doi: 10.1111/head.13554.
    PubMed     Text format     Abstract available
    
    
    
28. YARNITSKY D, Dodick DW, Grosberg BM, Burstein R, et al
    Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.
    Headache. 2019 May 9. doi: 10.1111/head.13551.
    PubMed     Text format     Abstract available
    
    
    
29. SKAJAA N, Szepligeti SK, Xue F, Sorensen HT, et al
    Pregnancy, Birth, Neonatal, and Postnatal Neurological Outcomes After Pregnancy With Migraine.
    Headache. 2019 May 8. doi: 10.1111/head.13536.
    PubMed     Text format     Abstract available
    
    
    
30. MCGINLEY JS, Buse DC, Shulman KJ, Wirth RJ, et al
    Evaluating Mean Level and Within-Person Consistency in Migraine Pain Intensity and Migraine-Related Disability for AVP-825 vs Oral Sumatriptan: Results from the COMPASS Study, A Randomized Trial.
    Headache. 2019 May 7. doi: 10.1111/head.13530.
    PubMed     Text format     Abstract available
    
    
    
31. BERGER A, Litwin J, Allen IE, Qubty W, et al
    Preliminary Evidence that Melatonin Is not a Biomarker With Children and Adolescents With Episodic Migraine.
    Headache. 2019 May 3. doi: 10.1111/head.13547.
    PubMed     Text format     Abstract available
    
    
    
32. LIU L, Yu Y, He J, Guo L, et al
    Effects of MTHFR C677T and A1298C Polymorphisms on Migraine Susceptibility: A Meta-Analysis of 26 Studies.
    Headache. 2019 May 2. doi: 10.1111/head.13540.
    PubMed     Text format     Abstract available
    
    
    April 2019
33. YOUNG NP, Philpot LM, Vierkant RA, Rosedahl JK, et al
    Episodic and Chronic Migraine in Primary Care.
    Headache. 2019 Apr 29. doi: 10.1111/head.13543.
    PubMed     Text format     Abstract available
    
    
    
34. HARGREAVES R, Olesen J
    Calcitonin Gene-Related Peptide Modulators - The History and Renaissance of a New Migraine Drug Class.
    Headache. 2019 Apr 25. doi: 10.1111/head.13510.
    PubMed     Text format     Abstract available
    
    
    
35. GELFAND AA, Pavitt S, Greene K, Szperka CL, et al
    High School Start Time and Migraine Frequency in High School Students.
    Headache. 2019 Apr 24. doi: 10.1111/head.13535.
    PubMed     Text format     Abstract available
    
    
    
36. GOLIKHATIR I, Cheraghmakani H, Bozorgi F, Jahanian F, et al
    The Efficacy and Safety of Prochlorperazine in Patients With Acute Migraine: A Systematic Review and Meta-Analysis.
    Headache. 2019 Apr 16. doi: 10.1111/head.13527.
    PubMed     Text format     Abstract available
    
    
    
37. IYENGAR S, Johnson KW, Ossipov MH, Aurora SK, et al
    CGRP and the Trigeminal System in Migraine.
    Headache. 2019 Apr 14. doi: 10.1111/head.13529.
    PubMed     Text format     Abstract available
    
    
    
38. SILBERSTEIN SD, McAllister P, Ning X, Faulhaber N, et al
    Safety and Tolerability of Fremanezumab for the Prevention of Migraine: A Pooled Analysis of Phases 2b and 3 Clinical Trials.
    Headache. 2019 Apr 12. doi: 10.1111/head.13534.
    PubMed     Text format     Abstract available
    
    
    
39. KLAN T, Liesering-Latta E, Gaul C, Martin PR, et al
    An Integrative Cognitive Behavioral Therapy Program for Adults With Migraine: A Feasibility Study.
    Headache. 2019 Apr 10. doi: 10.1111/head.13532.
    PubMed     Text format     Abstract available
    
    
    
40. HINDIYEH NA, Kellerman DJ, Schmidt PC
    Review of Acute Treatment of Migraine Trial Results With the New FDA Endpoints: Design Implications for Future Trials.
    Headache. 2019 Apr 6. doi: 10.1111/head.13511.
    PubMed     Text format     Abstract available
    
    
    
41. STAUFFER VL, Wang S, Voulgaropoulos M, Skljarevski V, et al
    Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results From 2 Randomized Phase 3 Trials.
    Headache. 2019 Apr 3. doi: 10.1111/head.13508.
    PubMed     Text format     Abstract available
    
    
    
42. BOES CJ
    Comment on "Chronic Migraine - Evolution of the Concept and Clinical Implications".
    Headache. 2019;59:623.
    PubMed     Text format    
    
    
    
43. ROSEN N, Pearlman E, Ruff D, Day K, et al
    Response to Misused and Misleading: 100% Response Rate to Galcanezumab in Patients With Episodic Migraine.
    Headache. 2019;59:627-628.
    PubMed     Text format    
    
    
    
44. ANSARI H
    Choose Wisely: Adapt the Classification Characteristic for Migraine Trigger Points.
    Headache. 2019;59:621-622.
    PubMed     Text format    
    
    
    
45. CHARLES JA, Rapoport AM
    The American Headache Society's Position Statement on Integrating New Migraine Treatments into Clinical Practice - Comments.
    Headache. 2019;59:629.
    PubMed     Text format    
    
    
    
46. STEINER TJ, Tfelt-Hansen P
    Misused and Misleading: "100% Response Rate" to Galcanezumab in Patients With Episodic Migraine.
    Headache. 2019;59:626.
    PubMed     Text format    
    
    
    
47. RIST PM, Hernandez A, Bernstein C, Kowalski M, et al
    The Impact of Spinal Manipulation on Migraine Pain and Disability: A Systematic Review and Meta-Analysis.
    Headache. 2019;59:532-542.
    PubMed     Text format     Abstract available
    
    
    
48. COWAN RP
    Toward a Philosophy of Migraine.
    Headache. 2019;59:481-483.
    PubMed     Text format    
    
    
    
49. VIGANO A, Manica A, Di Piero V, Leonardi M, et al
    Did Going North Give Us Migraine? An Evolutionary Approach on Understanding Latitudinal Differences in Migraine Epidemiology.
    Headache. 2019;59:632-634.
    PubMed     Text format     Abstract available
    
    
    
50. RUSSO A, Silvestro M, Tessitore A, Tedeschi G, et al
    Recent Insights in Migraine With Aura: A Narrative Review of Advanced Neuroimaging.
    Headache. 2019;59:637-649.
    PubMed     Text format     Abstract available
    
    
    March 2019
51. TRAHAN EM, Mercado JM
    Familial Hemiplegic Migraines and Baseline Neuropsychological Testing: A Case Report.
    Headache. 2019 Mar 14. doi: 10.1111/head.13505.
    PubMed     Text format     Abstract available
    
    
    
52. SPECK RM, Shalhoub H, Wyrwich KW, Yu R, et al
    Psychometric Validation of the Role Function Restrictive Domain of the Migraine Specific Quality-of-Life Questionnaire Version 2.1 Electronic Patient-Reported Outcome in Patients With Episodic and Chronic Migraine.
    Headache. 2019 Mar 12. doi: 10.1111/head.13497.
    PubMed     Text format     Abstract available
    
    
    
53. MANSFIELD C, Gebben DJ, Sutphin J, Tepper SJ, et al
    Patient Preferences for Preventive Migraine Treatments: A Discrete-Choice Experiment.
    Headache. 2019 Mar 12. doi: 10.1111/head.13498.
    PubMed     Text format     Abstract available
    
    
    
54. YILDIZ FG, Turkyilmaz U, Unal-Cevik I
    The Clinical Characteristics and Neurophysiological Assessments of the Occipital Cortex in Visual Snow Syndrome With or Without Migraine.
    Headache. 2019 Mar 8. doi: 10.1111/head.13494.
    PubMed     Text format     Abstract available
    
    
    
55. TEPPER DE
    Calcitonin Gene-Related Protein (CGRP)-Targeted Treatments for Migraine Prevention.
    Headache. 2019;59:477-480.
    PubMed     Text format    
    
    
    February 2019
56. GRINBERG AS, Seng EK
    Cross-Sectional Evaluation of the Psychometric Properties of the Headache-Specific Locus of Control Scale in People With Migraine.
    Headache. 2019 Feb 19. doi: 10.1111/head.13485.
    PubMed     Text format     Abstract available
    
    
    
57. BEH SC, Masrour S, Smith SV, Friedman DI, et al
    The Spectrum of Vestibular Migraine: Clinical Features, Triggers, and Examination Findings.
    Headache. 2019 Feb 8. doi: 10.1111/head.13484.
    PubMed     Text format     Abstract available
    
    
    
58. HAYNE DP, Martin PR
    Relating Photophobia, Visual Aura, and Visual Triggers of Headache and Migraine.
    Headache. 2019 Feb 8. doi: 10.1111/head.13486.
    PubMed     Text format     Abstract available
    
    
    January 2019
59. TEPPER SJ, Dodick DW, Schmidt PC, Kellerman DJ, et al
    Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches.
    Headache. 2019 Jan 30. doi: 10.1111/head.13482.
    PubMed     Text format     Abstract available
    
    
    
60. ANDROULAKIS XM, Sen S, Kodumuri N, Zhang T, et al
    Migraine Age of Onset and Association With Ischemic Stroke in Late Life: 20 Years Follow-Up in ARIC.
    Headache. 2019 Jan 21. doi: 10.1111/head.13468.
    PubMed     Text format     Abstract available
    
    
    
61. PERES MFP, Oliveira AB, Mercante JP, Kamei HH, et al
    Optimism, Pessimism, and Migraine: A Cross-Sectional, Population-Based Study.
    Headache. 2019 Jan 19. doi: 10.1111/head.13471.
    PubMed     Text format     Abstract available
    
    
    
62. SONG TJ, Cho SJ, Kim WJ, Yang KI, et al
    Sex Differences in Prevalence, Symptoms, Impact, and Psychiatric Comorbidities in Migraine and Probable Migraine: A Population-Based Study.
    Headache. 2019 Jan 9. doi: 10.1111/head.13470.
    PubMed     Text format     Abstract available
    
    
    
63. MANCINI V, Mastria G, Frantellizzi V, Troiani P, et al
    Migrainous Infarction in a Patient With Sporadic Hemiplegic Migraine and Cystic Fibrosis: A 99mTc-HMPAO Brain SPECT Study.
    Headache. 2019 Jan 8. doi: 10.1111/head.13472.
    PubMed     Text format     Abstract available
    
    
    
64. YOUNG WB
    The Effect of Onabotulinum Toxin on Aura Frequency and Severity in Patients With Hemiplegic Migraine - A Comment.
    Headache. 2019;59:110.
    PubMed     Text format    
    
    
    December 2018
65. BUSE DC, Greisman JD, Baigi K, Lipton RB, et al
    Migraine Progression: A Systematic Review.
    Headache. 2018 Dec 27. doi: 10.1111/head.13459.
    PubMed     Text format     Abstract available
    
    
    
66. ROGANTE E, Sarubbi S, Lamis DA, Canzonetta V, et al
    Illness Perception and Job Satisfaction in Patients Suffering from Migraine Headaches: Trait Anxiety and Depressive Symptoms as Potential Mediators.
    Headache. 2018 Dec 13. doi: 10.1111/head.13461.
    PubMed     Text format     Abstract available
    
    
    
67. 
    The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice.
    Headache. 2018 Dec 10. doi: 10.1111/head.13456.
    PubMed     Text format     Abstract available
    
    
    
68. MAGALHAES JE, Barros IML, Pedrosa RP, Sampaio Rocha-Filho PA, et al
    Migraine and Markers of Carotid Atherosclerosis in Middle-Aged Women: A Cross-Sectional Study.
    Headache. 2018 Dec 5. doi: 10.1111/head.13460.
    PubMed     Text format     Abstract available
    
    
    November 2018
69. WOLDEAMANUEL YW, DeSouza DD, Sanjanwala BM, Cowan RP, et al
    Clinical Features Contributing to Cortical Thickness Changes in Chronic Migraine - A Pilot Study.
    Headache. 2018 Nov 23. doi: 10.1111/head.13452.
    PubMed     Text format     Abstract available
    
    
    
70. NICHOLS R, Doty E, Sacco S, Ruff D, et al
    Analysis of Initial Nonresponders to Galcanezumab in Patients With Episodic or Chronic Migraine: Results From the EVOLVE-1, EVOLVE-2, and REGAIN Randomized, Double-Blind, Placebo-Controlled Studies.
    Headache. 2018 Nov 21. doi: 10.1111/head.13443.
    PubMed     Text format     Abstract available
    
    
    
71. SILBERSTEIN SD, Rapoport AM, Loupe PS, Aycardi E, et al
    The Effect of Beginning Treatment With Fremanezumab on Headache and Associated Symptoms in the Randomized Phase 2 Study of High Frequency Episodic Migraine: Post-Hoc Analyses on the First 3 Weeks of Treatment.
    Headache. 2018 Nov 18. doi: 10.1111/head.13446.
    PubMed     Text format     Abstract available
    
    
    
72. LIU Y, Li S, Wang R, Han X, et al
    A New Perspective of Migraine Symptoms in Patients With Congenital Heart Defect.
    Headache. 2018 Nov 16. doi: 10.1111/head.13453.
    PubMed     Text format     Abstract available
    
    
    
73. KROON VAN DIEST AM, Powers SW
    Cognitive Behavioral Therapy for Pediatric Headache and Migraine: Why to Prescribe and What New Research Is Critical for Advancing Integrated Biobehavioral Care.
    Headache. 2018 Nov 16. doi: 10.1111/head.13438.
    PubMed     Text format     Abstract available
    
    
    
74. LEVIN M, Silberstein SD, Gilbert R, Lucas S, et al
    Basic Considerations for the Use of Monoclonal Antibodies in Migraine.
    Headache. 2018 Nov 13. doi: 10.1111/head.13439.
    PubMed     Text format     Abstract available
    
    
    
75. HAMILTON KT, Robbins MS
    Migraine Treatment in Pregnant Women Presenting to Acute Care: A Retrospective Observational Study.
    Headache. 2018 Nov 7. doi: 10.1111/head.13434.
    PubMed     Text format     Abstract available
    
    
    
76. BUSE DC, Rains JC, Pavlovic JM, Fanning KM, et al
    Sleep Disorders Among People With Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
    Headache. 2018 Nov 1. doi: 10.1111/head.13435.
    PubMed     Text format     Abstract available
    
    
    October 2018
77. SENG EK, Mauser ED, Marzouk M, Patel ZS, et al
    When Mom Has Migraine: An Observational Study of the Impact of Parental Migraine on Adolescent Children.
    Headache. 2018 Oct 31. doi: 10.1111/head.13433.
    PubMed     Text format     Abstract available
    
    
    
78. SILBERSTEIN SD, Lee L, Gandhi K, Fitzgerald T, et al
    Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine.
    Headache. 2018 Oct 30. doi: 10.1111/head.13421.
    PubMed     Text format     Abstract available
    
    
    
79. HAREENDRAN A, Skalicky A, Mannix S, Lavoie S, et al
    Development of a New Tool for Evaluating the Benefit of Preventive Treatments for Migraine on Functional Outcomes - The Migraine Functional Impact Questionnaire (MFIQ).
    Headache. 2018 Oct 30. doi: 10.1111/head.13420.
    PubMed     Text format     Abstract available
    
    
    
80. LODER EW, Rayhill M, Burch RC
    Safety Problems With a Transdermal Patch for Migraine: Lessons From the Development, Approval, and Marketing Process.
    Headache. 2018 Oct 27. doi: 10.1111/head.13424.
    PubMed     Text format     Abstract available
    
    
    
81. SORGENFREI V, Kropp P, Straube A, Ruscheweyh R, et al
    High Achievement Motivation is Not Related to Increased Use of Acute Headache Medication in Migraine: A Cross-sectional Observational Cohort Study.
    Headache. 2018 Oct 27. doi: 10.1111/head.13431.
    PubMed     Text format     Abstract available
    
    
    
82. MARISSA LAGMAN-BARTOLOME A, Lay C
    The Traffic Light of Headache: Simplifying Acute Migraine Management for Physicians and Patients Using the Canadian Headache Society Guidelines.
    Headache. 2018 Oct 27. doi: 10.1111/head.13428.
    PubMed     Text format     Abstract available
    
    
    
83. TOGHA M, Razeghi Jahromi S, Ghorbani Z, Martami F, et al
    Serum Vitamin D Status in a Group of Migraine Patients Compared With Healthy Controls: A Case-Control Study.
    Headache. 2018 Oct 20. doi: 10.1111/head.13423.
    PubMed     Text format     Abstract available
    
    
    
84. COWAN RP
    The Future of Migraine Prevention.
    Headache. 2018 Oct 12. doi: 10.1111/head.13418.
    PubMed     Text format     Abstract available
    
    
    
85. DODICK DW, Tepper SJ, Lipton RB, Buse DC, et al
    Improving Medical Communication in Migraine Management: A Modified Delphi Study to Develop a Digital Migraine Tracker.
    Headache. 2018;58:1358-1372.
    PubMed     Text format     Abstract available
    
    
    
86. ROSEN N, Pearlman E, Ruff D, Day K, et al
    100% Response Rate to Galcanezumab in Patients With Episodic Migraine: A Post Hoc Analysis of the Results From Phase 3, Randomized, Double-Blind, Placebo-Controlled EVOLVE-1 and EVOLVE-2 Studies.
    Headache. 2018;58:1347-1357.
    PubMed     Text format     Abstract available
    
    
    
87. LIPTON RB, Munjal S, Alam A, Buse DC, et al
    Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.
    Headache. 2018;58:1408-1426.
    PubMed     Text format     Abstract available
    
    
    September 2018
88. SCHINDLER EAD, Wright DA, Weil MJ, Gottschalk CH, et al
    Survey Analysis of the Use, Effectiveness, and Patient-Reported Tolerability of Inhaled Oxygen Compared With Injectable Sumatriptan for the Acute Treatment of Cluster Headache.
    Headache. 2018 Sep 17. doi: 10.1111/head.13405.
    PubMed     Text format     Abstract available
    
    
    
89. WIELS W, Ourtani A, Van Binst AM, De Raedt S, et al
    Migrainous Headache Accompanied by Hemi-Atrophy of the Tongue in Carotid Artery Dissection.
    Headache. 2018 Sep 17. doi: 10.1111/head.13412.
    PubMed     Text format    
    
    
    
90. BERNSTEIN C, Shifren J, Maleki N
    Need for Migraine/Perimenopausal Research.
    Headache. 2018 Sep 8. doi: 10.1111/head.13406.
    PubMed     Text format    
    
    
    
91. MEDREA I, Christi S
    Chronic Migraine - Evolution of the Concept and Clinical Implications.
    Headache. 2018 Sep 4. doi: 10.1111/head.13380.
    PubMed     Text format     Abstract available
    
    
    
92. DE RU JA
    Choose Wisely: Adapt the Classification Characteristics for "Migraine Trigger Points".
    Headache. 2018;58:1256.
    PubMed     Text format    
    
    
    August 2018
93. HOWARD L, Dumkrieger G, Chong CD, Ross K, et al
    Symptoms of Autonomic Dysfunction Among Those With Persistent Posttraumatic Headache Attributed to Mild Traumatic Brain Injury: A Comparison to Migraine and Healthy Controls.
    Headache. 2018 Aug 29. doi: 10.1111/head.13396.
    PubMed     Text format     Abstract available
    
    
    
94. FRIEDMAN BW, Mohamed S, Robbins MS, Irizarry E, et al
    A Randomized, Sham-Controlled Trial of Bilateral Greater Occipital Nerve Blocks With Bupivacaine for Acute Migraine Patients Refractory to Standard Emergency Department Treatment With Metoclopramide.
    Headache. 2018 Aug 25. doi: 10.1111/head.13395.
    PubMed     Text format     Abstract available
    
    
    
95. LODER E, Rizzoli P
    Pharmacologic Prevention of Migraine: A Narrative Review of the State of the Art in 2018.
    Headache. 2018 Aug 23. doi: 10.1111/head.13375.
    PubMed     Text format     Abstract available
    
    
    
96. BENORE E, Webster EE, Wang L, Banez G, et al
    Longitudinal Analysis of Patient-Reported Outcomes From an Interdisciplinary Pediatric Pain Rehabilitation Program for Children With Chronic Migraine and Headache.
    Headache. 2018 Aug 23. doi: 10.1111/head.13389.
    PubMed     Text format     Abstract available
    
    
    
97. SCARATTI C, Covelli V, Guastafierro E, Leonardi M, et al
    A Qualitative Study On Patients With Chronic Migraine With Medication Overuse Headache: Comparing Frequent And Non-Frequent Relapsers.
    Headache. 2018 Aug 20. doi: 10.1111/head.13385.
    PubMed     Text format     Abstract available
    
    
    
98. MAGALHAES JE, Sampaio Rocha-Filho PA
    Migraine and cerebrovascular diseases: Epidemiology, pathophysiological, and clinical considerations.
    Headache. 2018 Aug 17. doi: 10.1111/head.13378.
    PubMed     Text format     Abstract available
    
    
    
99. QURESHI AI, Naseem N, Saleem MA, Potluri A, et al
    Migraine and Non-Migraine Headaches Following Diagnostic Catheter-Based Cerebral Angiography.
    Headache. 2018 Aug 16. doi: 10.1111/head.13377.
    PubMed     Text format     Abstract available
    
    
    
100. AYER DW, Skljarevski V, Ford JH, Nyhuis AW, et al
     Measures of Functioning in Patients With Episodic Migraine: Findings From a Double-Blind, Randomized, Placebo-Controlled Phase 2b Trial With Galcanezumab.
     Headache. 2018 Aug 14. doi: 10.1111/head.13383.
     PubMed     Text format     Abstract available
     
     
     
101. RAINS JC
     Sleep and Migraine: Assessment and Treatment of Comorbid Sleep Disorders.
     Headache. 2018 Aug 10. doi: 10.1111/head.13357.
     PubMed     Text format     Abstract available
     
     
     
102. VGONTZAS A, Pavlovic JM
     Sleep Disorders and Migraine: Review of Literature and Potential Pathophysiology Mechanisms.
     Headache. 2018 Aug 8. doi: 10.1111/head.13358.
     PubMed     Text format     Abstract available
     
     
     July 2018
103. MEHTA D, Leary MC, Yacoub HA, El-Hunjul M, et al
     The Effect of Regional Anesthetic Sphenopalatine Ganglion Block on Self-Reported Pain in Patients With Status Migrainosus.
     Headache. 2018 Jul 25. doi: 10.1111/head.13390.
     PubMed     Text format     Abstract available
     
     
     
104. CADY R, Lipton RB
     Qualitative Change in Migraine Prevention?
     Headache. 2018 Jul 23. doi: 10.1111/head.13354.
     PubMed     Text format     Abstract available
     
     
     
105. OLIVER JD, Boesch RP, Mack KJ
     Decreased Pulmonary Function During Botulinum Toxin A Therapy for Chronic Migraines in a 17-Year-Old Female.
     Headache. 2018 Jul 22. doi: 10.1111/head.13359.
     PubMed     Text format    
     
     
     
106. LIPTON RB, Fanning KM, Buse DC, Martin VT, et al
     Identifying Natural Subgroups of Migraine Based on Comorbidity and Concomitant Condition Profiles: Results of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
     Headache. 2018 Jul 19. doi: 10.1111/head.13342.
     PubMed     Text format     Abstract available
     
     
     
107. MINEN MT, Stieglitz EJ, Sciortino R, Torous J, et al
     Privacy Issues in Smartphone Applications: An Analysis of Headache/Migraine Applications.
     Headache. 2018 Jul 4. doi: 10.1111/head.13341.
     PubMed     Text format     Abstract available
     
     
     
108. LAW EF, Wan Tham S, Aaron RV, Dudeney J, et al
     Hybrid Cognitive-Behavioral Therapy Intervention for Adolescents With Co-Occurring Migraine and Insomnia: A Single-Arm Pilot Trial.
     Headache. 2018;58:1060-1073.
     PubMed     Text format     Abstract available
     
     
     
109. SMITHERMAN TA
     Foreword: Special Collection on Sleep Disorders and Migraine.
     Headache. 2018;58:1028-1029.
     PubMed     Text format    
     
     
     
110. BEH SC
     Horizontal Direction-Changing Positional Nystagmus and Vertigo: A Case of Vestibular Migraine Masquerading as Horizontal Canal BPPV.
     Headache. 2018;58:1113-1117.
     PubMed     Text format     Abstract available
     
     
     
111. BARON EP
     Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science.
     Headache. 2018;58:1139-1186.
     PubMed     Text format     Abstract available
     
     
     
112. MAGGIONI F
     When Can We, Really, Talk About Status Migrainosus in Migraine With Aura?
     Headache. 2018;58:1120-1121.
     PubMed     Text format    
     
     
     June 2018
113. VELICKOVIC OSTOJIC L, Liang JW, Sheikh HU, Dhamoon MS, et al
     Impact of Aura and Status Migrainosus on Readmissions for Vascular Events After Migraine Admission.
     Headache. 2018 Jun 22. doi: 10.1111/head.13347.
     PubMed     Text format     Abstract available
     
     
     
114. ORR SL, Kabbouche MA, Horn PS, O'Brien HL, et al
     Predictors of First-Line Treatment Success in Children and Adolescents Visiting an Infusion Center for Acute Migraine.
     Headache. 2018 Jun 21. doi: 10.1111/head.13340.
     PubMed     Text format     Abstract available
     
     
     
115. HANSON LL, Ahmed Z, Katz BJ, Warner JEA, et al
     Patients With Migraine Have Substantial Reductions in Measures of Visual Quality of Life.
     Headache. 2018 Jun 7. doi: 10.1111/head.13330.
     PubMed     Text format     Abstract available
     
     
     
116. SENG EK, Kuka AJ, Mayson SJ, Smitherman TA, et al
     Acceptance, Psychiatric Symptoms, and Migraine Disability: An Observational Study in a Headache Center.
     Headache. 2018;58:859-872.
     PubMed     Text format     Abstract available
     
     
     May 2018
117. DODICK DW, Tepper SJ, Friedman DI, Gelfand AA, et al
     Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial.
     Headache. 2018 May 21. doi: 10.1111/head.13327.
     PubMed     Text format     Abstract available
     
     
     
118. EVANS RW
     Post traumatic Episodic Status Migrainosus.
     Headache. 2018 May 20. doi: 10.1111/head.13326.
     PubMed     Text format    
     
     
     
119. CHEN TY, Garza I, Dodick DW, Robertson CE, et al
     The Effect of OnabotulinumtoxinA on Aura Frequency and Severity in Patients With Hemiplegic Migraine: Case Series of 11 Patients.
     Headache. 2018 May 15. doi: 10.1111/head.13317.
     PubMed     Text format     Abstract available
     
     
     
120. SMITHERMAN TA, Kuka AJ, Calhoun AH, Walters ABP, et al
     Cognitive-Behavioral Therapy for Insomnia to Reduce Chronic Migraine: A Sequential Bayesian Analysis.
     Headache. 2018 May 6. doi: 10.1111/head.13313.
     PubMed     Text format     Abstract available
     
     
     
121. BUSE DC, Gillard P, Arctander K, Kuang AW, et al
     Assessing Physician-Patient Dialogues About Chronic Migraine During Routine Office Visits.
     Headache. 2018 May 4. doi: 10.1111/head.13314.
     PubMed     Text format     Abstract available
     
     
     
122. ONG JC, Taylor HL, Park M, Burgess HJ, et al
     Can Circadian Dysregulation Exacerbate Migraines?
     Headache. 2018 May 4. doi: 10.1111/head.13310.
     PubMed     Text format     Abstract available
     
     
     
123. REUTER U
     A Review of Monoclonal Antibody Therapies and Other Preventative Treatments in Migraine.
     Headache. 2018;58 Suppl 1:48-59.
     PubMed     Text format     Abstract available
     
     
     
124. HOLLAND PR
     Foreword: The CGRP Pathway and Migraine Prevention: Reducing the Burden of Disease.
     Headache. 2018;58 Suppl 1:1-3.
     PubMed     Text format    
     
     
     
125. DODICK DW
     A Phase-by-Phase Review of Migraine Pathophysiology.
     Headache. 2018;58 Suppl 1:4-16.
     PubMed     Text format     Abstract available
     
     
     
126. EDVINSSON L
     The CGRP Pathway in Migraine as a Viable Target for Therapies.
     Headache. 2018;58 Suppl 1:33-47.
     PubMed     Text format     Abstract available
     
     
     
127. AGOSTI R
     Migraine Burden of Disease: From the Patient's Experience to a Socio-Economic View.
     Headache. 2018;58 Suppl 1:17-32.
     PubMed     Text format     Abstract available
     
     
     
128. KREBS K, Rorden C, Androulakis XM
     Resting State Functional Connectivity After Sphenopalatine Ganglion Blocks in Chronic Migraine With Medication Overuse Headache: A Pilot Longitudinal fMRI Study.
     Headache. 2018;58:732-743.
     PubMed     Text format     Abstract available
     
     
     
129. CHARLESTON L 4TH, Royce J, Monteith TS, Broner SW, et al
     Migraine Care Challenges and Strategies in US Uninsured and Underinsured Adults: A Narrative Review, Part 2.
     Headache. 2018;58:633-647.
     PubMed     Text format     Abstract available
     
     
     
130. LIPTON RB, Munjal S, Brand-Schieber E, Rapoport AM, et al
     DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study.
     Headache. 2018;58:676-687.
     PubMed     Text format     Abstract available
     
     
     April 2018
131. BEH SC
     A Case of Vestibular Migraine Resolving on Warfarin and Topiramate.
     Headache. 2018;58:599-600.
     PubMed     Text format    
     
     
     
132. TEPPER SJ
     Editorial: Understanding Menstrual Migraine.
     Headache. 2018;58:625.
     PubMed     Text format    
     
     
     
133. LUIZON MR, Goncalves FM, Dach F
     Gene-Gene Interactions Implicated in Vascular Endothelial Function in Migraine.
     Headache. 2018;58:601-602.
     PubMed     Text format    
     
     
     March 2018
134. IRWIN SL, Qubty W, Allen IE, Patniyot I, et al
     Transcranial Magnetic Stimulation for Migraine Prevention in Adolescents: A Pilot Open-Label Study.
     Headache. 2018 Mar 12. doi: 10.1111/head.13284.
     PubMed     Text format     Abstract available
     
     
     
135. BURCH R, Rizzoli P, Loder E
     The Prevalence and Impact of Migraine and Severe Headache in the United States: Figures and Trends From Government Health Studies.
     Headache. 2018 Mar 12. doi: 10.1111/head.13281.
     PubMed     Text format     Abstract available
     
     
     
136. FRIEDMAN BW, Latev A, Campbell C, White D, et al
     Opioid-Induced "Likeability" and "Feeling Good" Are Not Associated With Return Visits to an ED Among Migraine Patients Administered IV Hydromorphone.
     Headache. 2018 Mar 8. doi: 10.1111/head.13292.
     PubMed     Text format     Abstract available
     
     
     
137. KROON VAN DIEST AM, Ernst MM, Vaughn L, Slater S, et al
     CBT for Pediatric Migraine: A Qualitative Study of Patient and Parent Experience.
     Headache. 2018 Mar 8. doi: 10.1111/head.13285.
     PubMed     Text format     Abstract available
     
     
     
138. CHARLESTON L 4TH, Royce J, Monteith TS, Broner SW, et al
     Migraine Care Challenges and Strategies in US Uninsured and Underinsured Adults: A Narrative Review, Part 1.
     Headache. 2018 Mar 8. doi: 10.1111/head.13286.
     PubMed     Text format     Abstract available
     
     
     
139. PURDY RA
     Neurobiological Basis of Migraine.
     Headache. 2018 Mar 6. doi: 10.1111/head.13296.
     PubMed     Text format    
     
     
     
140. CALHOUN AH
     Understanding Menstrual Migraine.
     Headache. 2018 Mar 1. doi: 10.1111/head.13291.
     PubMed     Text format     Abstract available
     
     
     February 2018
141. SINGH AS
     Mirror Induced Headaches: A New Self Image Trigger for Migraine Attacks?
     Headache. 2018 Feb 28. doi: 10.1111/head.13293.
     PubMed     Text format    
     
     
     
142. BONAFEDE M, Sapra S, Shah N, Tepper S, et al
     Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
     Headache. 2018 Feb 15. doi: 10.1111/head.13275.
     PubMed     Text format     Abstract available
     
     
     
143. PERETZ AM, Minen MT, Cowan R, Strauss LD, et al
     Introducing the Migraine Action Plan.
     Headache. 2018;58:195.
     PubMed     Text format    
     
     
     
144. LEIVA-CALDERON A, Mayorga-Moreno RJ
     Fibromyalgia Among Patients With Chronic Migraine and Chronic Tension-Type Headache: A Multicenter Prospective Cross-Sectional Study: A Comment.
     Headache. 2018;58:309-310.
     PubMed     Text format    
     
     
     
145. CHO SJ, Sohn JH, Bae JS, Chu MK, et al
     Fibromyalgia Among Patients With Chronic Migraine and Chronic Tension-Type Headache: A Multicenter Prospective Cross-Sectional Study - A Response.
     Headache. 2018;58:311-312.
     PubMed     Text format    
     
     
     
146. PERETZ AM, Minen MT, Cowan R, Strauss LD, et al
     Migraine Action Plan (MAP).
     Headache. 2018;58:355-356.
     PubMed     Text format    
     
     
     
147. PERCIACCANTE A, Abenavoli L, Coralli A, Charlier P, et al
     The Complex Aura of Nikola Tesla.
     Headache. 2018;58:304-305.
     PubMed     Text format    
     
     
     
148. WEI DY, Greenwood FS, Murgatroyd FD, Goadsby PJ, et al
     Case Report of the Safety Assessment of Transcranial Magnetic Stimulation Use in a Patient With Cardiac Pacemaker: To Pulse or Not to Pulse?
     Headache. 2018;58:295-297.
     PubMed     Text format     Abstract available
     
     
     
149. REDON S, Donnet A
     Sneezing in Primary Headaches With Cranial Autonomic Symptoms: Pathophysiological Considerations. A Series of Case Reports.
     Headache. 2018;58:298-303.
     PubMed     Text format     Abstract available
     
     
     
150. RABNER J, Kaczynski KJ, Simons LE, LeBel A, et al
     Pediatric Headache and Sleep Disturbance: A Comparison of Diagnostic Groups.
     Headache. 2018;58:217-228.
     PubMed     Text format     Abstract available
     
     
     January 2018
151. BUSE DC, Powers SW, Gelfand AA, VanderPluym JH, et al
     Adolescent Perspectives on the Burden of a Parent's Migraine: Results from the CaMEO Study.
     Headache. 2018 Jan 22. doi: 10.1111/head.13254.
     PubMed     Text format     Abstract available
     
     
     
152. PURDY RA
     Understanding Your Migraines: A Guide for Patients and Families.
     Headache. 2018 Jan 9. doi: 10.1111/head.13251.
     PubMed     Text format    
     
     
     
153. SHIPKOV H, Grozdev I
     Injection Patterns of Onabotulinumtoxin A in Migraine Headache.
     Headache. 2018;58:148-150.
     PubMed     Text format    
     
     
     
154. MAASUMI K, Tepper SJ, Kriegler JS
     Menstrual Migraine and Treatment Options-A Response.
     Headache. 2018;58:147.
     PubMed     Text format    
     
     
     
155. LICHTEN EM
     Menstrual Migraine and Treatment Options: Review.
     Headache. 2018;58:145-146.
     PubMed     Text format    
     
     
     
156. LUNA S, Lai D, Harris A
     Antagonistic Relationship Between VEP Potentiation and Gamma Power in Visual Snow Syndrome.
     Headache. 2018;58:138-144.
     PubMed     Text format     Abstract available
     
     
     
157. ALSTADHAUG KB, Ofte HK
     Spot On?
     Headache. 2018;58:136-137.
     PubMed     Text format    
     
     
     December 2017
158. DE RIJK P, Resseguier N, Donnet A
     Headache Characteristics and Clinical Features of Elderly Migraine Patients.
     Headache. 2017 Dec 13. doi: 10.1111/head.13247.
     PubMed     Text format     Abstract available
     
     
     
159. TEGGI R, Colombo B, Albera R, Asprella Libonati G, et al
     Clinical Features, Familial History, and Migraine Precursors in Patients With Definite Vestibular Migraine: The VM-Phenotypes Projects.
     Headache. 2017 Dec 4. doi: 10.1111/head.13240.
     PubMed     Text format     Abstract available
     
     
     November 2017
160. FRIEDMAN LE, Zhong QY, Gelaye B, Williams MA, et al
     Association Between Migraine and Suicidal Behaviors: A Nationwide Study in the USA.
     Headache. 2017 Nov 29. doi: 10.1111/head.13235.
     PubMed     Text format     Abstract available
     
     
     
161. MINEN MT, Anglin L, Boubour A, Squires A, et al
     Meta-Synthesis on Migraine Management.
     Headache. 2017 Nov 21. doi: 10.1111/head.13212.
     PubMed     Text format     Abstract available
     
     
     
162. SHEIKH HU, Pavlovic J, Loder E, Burch R, et al
     Risk of Stroke Associated With Use of Estrogen Containing Contraceptives in Women With Migraine: A Systematic Review.
     Headache. 2017 Nov 15. doi: 10.1111/head.13229.
     PubMed     Text format     Abstract available
     
     
     
163. YOUNG WB
     De-Stigmatizing Migraine - With Words.
     Headache. 2017 Nov 15. doi: 10.1111/head.13209.
     PubMed     Text format    
     
     
     
164. DOMINGUEZ C, Vieites-Prado A, Perez-Mato M, Sobrino T, et al
     CGRP and PTX3 as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine: An Observational Study.
     Headache. 2017 Nov 13. doi: 10.1111/head.13211.
     PubMed     Text format     Abstract available
     
     
     
165. VON LUCKNER A, Riederer F
     Magnesium in Migraine Prophylaxis-Is There an Evidence-Based Rationale? A Systematic Review.
     Headache. 2017 Nov 13. doi: 10.1111/head.13217.
     PubMed     Text format     Abstract available
     
     
     
166. YOU DS, Haney R, Albu S, Meagher MW, et al
     Generalized Pain Sensitization and Endogenous Oxytocin in Individuals With Symptoms of Migraine: A Cross-Sectional Study.
     Headache. 2017 Nov 2. doi: 10.1111/head.13213.
     PubMed     Text format     Abstract available
     
     
     
167. MINEN MT, Boubour A, Wahnich A, Grudzen C, et al
     A Retrospective Nested Cohort Study of Emergency Department Revisits for Migraine in New York City.
     Headache. 2017 Nov 2. doi: 10.1111/head.13216.
     PubMed     Text format     Abstract available
     
     
     
168. OSUMILI B, McCrone P, Cousins S, Ridsdale L, et al
     The Economic Cost of Patients With Migraine Headache Referred to Specialist Clinics.
     Headache. 2017 Nov 2. doi: 10.1111/head.13210.
     PubMed     Text format     Abstract available
     
     
     
169. FERDINANDO M, Alberto T, Giuseppe M, Federico M, et al
     Combination of NSAID and Triptan in Migraine Treatment and Cardiovascular Risk: Is It Safe?
     Headache. 2017;57:1622-1623.
     PubMed     Text format    
     
     
     October 2017
170. CHU HT, Liang CS, Lee JT, Yeh TC, et al
     Associations Between Depression/Anxiety and Headache Frequency in Migraineurs: A Cross-Sectional Study.
     Headache. 2017 Oct 18. doi: 10.1111/head.13215.
     PubMed     Text format     Abstract available
     
     
     
171. BORKUM JM
     The Migraine Attack as a Homeostatic, Neuroprotective Response to Brain Oxidative Stress: Preliminary Evidence for a Theory.
     Headache. 2017 Oct 16. doi: 10.1111/head.13214.
     PubMed     Text format     Abstract available
     
     
     
172. LIPTON RB, McGinley JS, Shulman KJ, Silberstein SD, et al
     AVP-825 (Sumatriptan Nasal Powder) Reduces Nausea Compared to Sumatriptan Tablets: Results of the COMPASS Randomized Clinical Trial.
     Headache. 2017 Oct 16. doi: 10.1111/head.13199.
     PubMed     Text format     Abstract available
     
     
     
173. KARMAKAR M, Elhai JD, Amialchuk AA, Tietjen GE, et al
     Do Personality Traits Mediate the Relationship Between Childhood Abuse and Migraine? An Exploration of the Relationships in Young Adults Using the Add Health Dataset.
     Headache. 2017 Oct 13. doi: 10.1111/head.13206.
     PubMed     Text format     Abstract available
     
     
     
174. LIPTON RB, Reed ML, Kurth T, Fanning KM, et al
     Framingham-Based Cardiovascular Risk Estimates Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study.
     Headache. 2017 Oct 9. doi: 10.1111/head.13179.
     PubMed     Text format     Abstract available
     
     
     
175. FORD JH, Jackson J, Milligan G, Cotton S, et al
     A Real-World Analysis of Migraine: A Cross-Sectional Study of Disease Burden and Treatment Patterns.
     Headache. 2017 Oct 6. doi: 10.1111/head.13202.
     PubMed     Text format     Abstract available
     
     
     
176. CHONG CD, Dumkrieger GM, Schwedt TJ
     Structural Co-Variance Patterns in Migraine: A Cross-Sectional Study Exploring the Role of the Hippocampus.
     Headache. 2017 Oct 4. doi: 10.1111/head.13193.
     PubMed     Text format     Abstract available
     
     
     
177. KRASENBAUM LJ
     A Review of Migraine Prophylaxis and Acute Treatment Patterns Among Commercially Insured Patients in the United States.
     Headache. 2017;57:1451-1452.
     PubMed     Text format    
     
     
     September 2017
178. GUVEN B, Guven H, Comoglu SS
     Migraine and Yawning.
     Headache. 2017 Sep 27. doi: 10.1111/head.13195.
     PubMed     Text format     Abstract available
     
     
     
179. NILSSON BG, Bungard TJ
     A Case of Migraine With Aura Resolving on Warfarin But Not on Apixaban.
     Headache. 2017 Sep 27. doi: 10.1111/head.13190.
     PubMed     Text format     Abstract available
     
     
     
180. ROGALINSKI S, Rambold HA
     Probing Early Motion Processing With Eye Movements: Differences of Vestibular Migraine, Migraine With and Without Aura in the Attack Free Interval.
     Headache. 2017 Sep 25. doi: 10.1111/head.13185.
     PubMed     Text format     Abstract available
     
     
     
181. CHO SJ, Sohn JH, Bae JS, Chu MK, et al
     Fibromyalgia Among Patients With Chronic Migraine and Chronic Tension-Type Headache: A Multicenter Prospective Cross-Sectional Study.
     Headache. 2017 Sep 22. doi: 10.1111/head.13191.
     PubMed     Text format     Abstract available
     
     
     
182. LEROUX E, Beaudet L, Boudreau G, Eghtesadi M, et al
     A Nursing Intervention Increases Quality of Life and Self-Efficacy in Migraine: A 1-Year Prospective Controlled Trial.
     Headache. 2017 Sep 15. doi: 10.1111/head.13178.
     PubMed     Text format     Abstract available
     
     
     
183. LIPTON RB, McGinley JS, Shulman KJ, Wirth RJ, et al
     Faster Improvement in Migraine Pain Intensity and Migraine-Related Disability at Early Time Points with AVP-825 (Sumatriptan Nasal Powder Delivery System) versus Oral Sumatriptan: A Comparative Randomized Clinical Trial Across Multiple Attacks from th
     Headache. 2017 Sep 7. doi: 10.1111/head.13165.
     PubMed     Text format     Abstract available
     
     
     
184. YUAN H, Silberstein SD
     Histamine and Migraine.
     Headache. 2017 Sep 1. doi: 10.1111/head.13164.
     PubMed     Text format     Abstract available
     
     
     
185. COHEN JM, Dodick DW, Yang R, Newman LC, et al
     Fremanezumab as Add-On Treatment for Patients Treated With Other Migraine Preventive Medicines.
     Headache. 2017 Sep 1. doi: 10.1111/head.13156.
     PubMed     Text format     Abstract available
     
     
     
186. KRASENBAUM LJ
     A Review of Complementary and Alternative Medicine Use Among U.S. Adults with Headache or Migraine: Results from the 2012 National Health Interview Survey.
     Headache. 2017;57:1284-1285.
     PubMed     Text format    
     
     
     August 2017
187. KAWATA AK, Hsieh R, Bender R, Shaffer S, et al
     Psychometric Evaluation of a Novel Instrument Assessing the Impact of Migraine on Physical Functioning: The Migraine Physical Function Impact Diary.
     Headache. 2017 Aug 30. doi: 10.1111/head.13162.
     PubMed     Text format     Abstract available
     
     
     
188. WOOLLEY JM, Bonafede MM, Maiese BA, Lenz RA, et al
     Migraine Prophylaxis and Acute Treatment Patterns Among Commercially Insured Patients in the United States.
     Headache. 2017 Aug 26. doi: 10.1111/head.13157.
     PubMed     Text format     Abstract available
     
     
     
189. BERGMAN-BOCK S
     Associations Between Migraine and the Most Common Psychiatric Co-Morbidities.
     Headache. 2017 Aug 10. doi: 10.1111/head.13146.
     PubMed     Text format     Abstract available
     
     
     July 2017
190. SAMPAIO ROCHA-FILHO PA, Hershey AD
     Pediatric Migraine Disability Assessment (PedMIDAS): Translation Into Brazilian Portuguese and Cross-Cultural Adaptation.
     Headache. 2017 Jul 28. doi: 10.1111/head.13159.
     PubMed     Text format     Abstract available
     
     
     
191. ZHANG Y, Dennis JA, Leach MJ, Bishop FL, et al
     Complementary and Alternative Medicine Use Among US Adults With Headache or Migraine: Results from the 2012 National Health Interview Survey.
     Headache. 2017 Jul 25. doi: 10.1111/head.13148.
     PubMed     Text format     Abstract available
     
     
     
192. VALENTE M, Janes F, Russo V, Fontana A, et al
     Prevalence of Restless Legs Syndrome in Migraine Patients: A Case-Control Study. Analysis of Risk Factors for Restless Legs Syndrome in Migraine Patients.
     Headache. 2017;57:1088-1095.
     PubMed     Text format     Abstract available
     
     
     
193. LIPTON RB, Pavlovic JM, Buse DC
     Why Migraine Forecasting Matters.
     Headache. 2017;57:1023-1025.
     PubMed     Text format    
     
     
     
194. KRASENBAUM LJ
     A Review of Allodynia Is Associated With Initial and Sustained Response to Acute Migraine Treatment: Results From the American Migraine Prevalence and Prevention Study.
     Headache. 2017;57:1156-1157.
     PubMed     Text format    
     
     
     
195. HOULE TT, Turner DP, Golding AN, Porter JAH, et al
     Forecasting Individual Headache Attacks Using Perceived Stress: Development of a Multivariable Prediction Model for Persons With Episodic Migraine.
     Headache. 2017;57:1041-1050.
     PubMed     Text format     Abstract available
     
     
     
196. GARCIA-MARTIN E, Martinez C, Serrador M, Alonso-Navarro H, et al
     Gamma-Aminobutyric Acid (Gaba) Receptors Rho (Gabrr) Gene Polymorphisms and Risk for Migraine.
     Headache. 2017;57:1118-1135.
     PubMed     Text format     Abstract available
     
     
     June 2017
197. BURNS SM, Turner DP, Sexton KE, Deng H, et al
     Using Search Engines to Investigate Shared Migraine Experiences.
     Headache. 2017 Jun 28. doi: 10.1111/head.13130.
     PubMed     Text format     Abstract available
     
     
     
198. WILKINSON D, Ade KK, Rogers LL, Attix DK, et al
     Preventing Episodic Migraine With Caloric Vestibular Stimulation: A Randomized Controlled Trial.
     Headache. 2017 Jun 27. doi: 10.1111/head.13120.
     PubMed     Text format     Abstract available
     
     
     
199. YADAV P, Bradley AL, Smith JH
     Recognition of Chronic Migraine by Medicine Trainees: A Cross-Sectional Survey.
     Headache. 2017 Jun 26. doi: 10.1111/head.13133.
     PubMed     Text format     Abstract available
     
     
     
200. BEKKELUND SI, Muller KI, Wilhelmsen A, Alstadhaug KB, et al
     Photophobia and Seasonal Variation of Migraine in a Subarctic Population.
     Headache. 2017 Jun 19. doi: 10.1111/head.13131.
     PubMed     Text format     Abstract available
     
     
     
201. SCHWEDT TJ, Si B, Li J, Wu T, et al
     Migraine Subclassification via a Data-Driven Automated Approach Using Multimodality Factor Mixture Modeling of Brain Structure Measurements.
     Headache. 2017 Jun 19. doi: 10.1111/head.13121.
     PubMed     Text format     Abstract available
     
     
     
202. LIPTON RB, Munjal S, Buse DC, Bennett A, et al
     Allodynia Is Associated With Initial and Sustained Response to Acute Migraine Treatment: Results from the American Migraine Prevalence and Prevention Study.
     Headache. 2017 Jun 11. doi: 10.1111/head.13115.
     PubMed     Text format     Abstract available
     
     
     
203. AMBROSINI A, D'Onofrio M, Buzzi MG, Arisi I, et al
     Possible Involvement of the CACNA1E Gene in Migraine: A Search for Single Nucleotide Polymorphism in Different Clinical Phenotypes.
     Headache. 2017 Jun 1. doi: 10.1111/head.13107.
     PubMed     Text format     Abstract available
     
     
     
204. SCHULTE L, May A
     Pearls and Pitfalls in Migraine Neuroimaging.
     Headache. 2017;57:850-851.
     PubMed     Text format    
     
     
     
205. KRASENBAUM LJ
     A Review of Vomiting and Migraine-Related Clinical Parameters in Pediatric Migraine.
     Headache. 2017;57:979-980.
     PubMed     Text format    
     
     
     
206. TEPPER DE
     Migraine in Children.
     Headache. 2017;57:1021-1022.
     PubMed     Text format    
     
     
     May 2017
207. BECKER WJ
     The Diagnosis and Management of Chronic Migraine in Primary Care.
     Headache. 2017 May 26. doi: 10.1111/head.13089.
     PubMed     Text format     Abstract available
     
     
     
208. VAN DEN BERG JSP, Steiner TJ, Veenstra PJL, Kollen BJ, et al
     Migraine Nurses in Primary Care: Costs and Benefits.
     Headache. 2017 May 19. doi: 10.1111/head.13098.
     PubMed     Text format     Abstract available
     
     
     
209. KISSOON NR, Cutrer FM
     Aura and Other Neurologic Dysfunction in or with Migraine.
     Headache. 2017 May 19. doi: 10.1111/head.13101.
     PubMed     Text format     Abstract available
     
     
     
210. BURNS R, De Malherbe M, Chadenat ML, Pico F, et al
     Arterial Spin-Labeled MR Imaging Detecting Biphasic Neurovascular Changes in Migraine With Persistent Aura.
     Headache. 2017 May 19. doi: 10.1111/head.13119.
     PubMed     Text format    
     
     
     
211. SILBERSTEIN S, Winner PK, McAllister PJ, Tepper SJ, et al
     Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered(R) Exhalation Delivery System (Sumatriptan Nasal Powder) vs Oral Sumatriptan.
     Headache. 2017 May 11. doi: 10.1111/head.13105.
     PubMed     Text format     Abstract available
     
     
     
212. HARTL E, Gonzalez-Victores JA, Remi J, Schankin CJ, et al
     Visual Auras in Epilepsy and Migraine - An Analysis of Clinical Characteristics.
     Headache. 2017 May 10. doi: 10.1111/head.13113.
     PubMed     Text format     Abstract available
     
     
     
213. PERROTTA A, Anastasio MG, De Icco R, Coppola G, et al
     Frequency-Dependent Habituation Deficit of the Nociceptive Blink Reflex in Aura With Migraine Headache. Can Migraine Aura Modulate Trigeminal Excitability?
     Headache. 2017 May 10. doi: 10.1111/head.13111.
     PubMed     Text format     Abstract available
     
     
     
214. EIDLITZ-MARKUS T, Haimi-Cohen Y, Zeharia A
     Vomiting and migraine-related clinical parameters in pediatric migraine.
     Headache. 2017 May 7. doi: 10.1111/head.13109.
     PubMed     Text format     Abstract available
     
     
     
215. SHAYESTAGUL NA, Christensen CE, Amin FM, Ashina S, et al
     Measurement of Blood Flow Velocity in the Middle Cerebral Artery During Spontaneous Migraine Attacks: A Systematic Review.
     Headache. 2017 May 3. doi: 10.1111/head.13106.
     PubMed     Text format     Abstract available
     
     
     
216. LENDVAI IS, Kinfe TM
     Migraine Improvement After Anterior Thalamic Deep Brain Stimulation for Drug-Resistant Idiopathic Generalized Seizure: A Case Report.
     Headache. 2017 May 2. doi: 10.1111/head.13097.
     PubMed     Text format    
     
     
     
217. MAGGIONI F, Terrin A, Maggioni G, Mainardi F, et al
     Olfactory Modifications in a Migraine Patient With Anosmia.
     Headache. 2017;57:801-802.
     PubMed     Text format    
     
     
     
218. EDVINSSON L
     The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine.
     Headache. 2017;57 Suppl 2:47-55.
     PubMed     Text format     Abstract available
     
     
     
219. TZABAZIS A, Kori S, Mechanic J, Miller J, et al
     Oxytocin and Migraine Headache.
     Headache. 2017;57 Suppl 2:64-75.
     PubMed     Text format     Abstract available
     
     
     
220. VOLLESEN ALH, Ashina M
     PACAP38: Emerging Drug Target in Migraine and Cluster Headache.
     Headache. 2017;57 Suppl 2:56-63.
     PubMed     Text format     Abstract available
     
     
     
221. NOSEDA R, Borsook D, Burstein R
     Neuropeptides and Neurotransmitters That Modulate Thalamo-Cortical Pathways Relevant to Migraine Headache.
     Headache. 2017;57 Suppl 2:97-111.
     PubMed     Text format     Abstract available
     
     
     
222. BLUMENFELD AM, Silberstein SD, Dodick DW, Aurora SK, et al
     Insights into the Functional Anatomy Behind the PREEMPT Injection Paradigm: Guidance on Achieving Optimal Outcomes.
     Headache. 2017;57:766-777.
     PubMed     Text format     Abstract available
     
     
     
223. EVANS RW
     Incidental Findings and Normal Anatomical Variants on MRI of the Brain in Adults for Primary Headaches.
     Headache. 2017;57:780-791.
     PubMed     Text format     Abstract available
     
     
     
224. FINKEL AG, Ivins BJ, Yerry JA, Klaric JS, et al
     Which Matters More? A Retrospective Cohort Study of Headache Characteristics and Diagnosis Type in Soldiers with mTBI/Concussion.
     Headache. 2017;57:719-728.
     PubMed     Text format     Abstract available
     
     
     April 2017
225. RUSSO A, Silvestro M, Tessitore A, Tedeschi G, et al
     "Forced Normalization": Could It Occur Also in Migraine Patients?
     Headache. 2017 Apr 8. doi: 10.1111/head.13079.
     PubMed     Text format    
     
     
     
226. LIPTON RB, Schmidt P, Diener HC
     Post Hoc Subanalysis of Two Randomized, Controlled Phase 3 Trials Evaluating Diclofenac Potassium for Oral Solution: Impact of Migraine-Associated Nausea and Prior Triptan Use on Efficacy.
     Headache. 2017 Apr 6. doi: 10.1111/head.13073.
     PubMed     Text format     Abstract available
     
     
     
227. HAY DL, Walker CS
     CGRP and its receptors.
     Headache. 2017;57:625-636.
     PubMed     Text format     Abstract available
     
     
     March 2017
228. LAW-YE B, Fargeot G, Leclercq D
     Arterial Spin Labeling Hypoperfusion in Migraine Aura.
     Headache. 2017 Mar 31. doi: 10.1111/head.13072.
     PubMed     Text format    
     
     
     
229. OINONEN SM
     Integrative Medicine: A Necessary Component in Completing Treatment for My Chronic Migraines.
     Headache. 2017 Mar 22. doi: 10.1111/head.13070.
     PubMed     Text format    
     
     
     
230. LILLIS J, Graham Thomas J, Seng EK, Lipton RB, et al
     Importance of Pain Acceptance in Relation to Headache Disability and Pain Interference in Women With Migraine and Overweight/Obesity.
     Headache. 2017 Mar 13. doi: 10.1111/head.13058.
     PubMed     Text format     Abstract available
     
     
     
231. PULEDDA F, Goadsby PJ
     An Update on Non-Pharmacological Neuromodulation for the Acute and Preventive Treatment of Migraine.
     Headache. 2017 Mar 13. doi: 10.1111/head.13069.
     PubMed     Text format     Abstract available
     
     
     
232. SUTHERLAND HG, Griffiths LR
     Genetics of Migraine: Insights into the Molecular Basis of Migraine Disorders.
     Headache. 2017 Mar 8. doi: 10.1111/head.13053.
     PubMed     Text format     Abstract available
     
     
     
233. ALI A, Rothner AD
     Migraine With Neurological Features in a Scuba Diver With a Patent Foramen Ovale.
     Headache. 2017 Mar 2. doi: 10.1111/head.13047.
     PubMed     Text format     Abstract available
     
     
     
234. SILVA-NETO RP, Almeida Soares A
     Does Migraine Occur Only in Humans or Other Animals May Suffer from This Disease Too?
     Headache. 2017;57:487.
     PubMed     Text format    
     
     
     
235. KRASENBAUM LJ
     A Review of "Untangling the Association Between Migraine, Pain, and Anxiety: Examining Migraine and Generalized Anxiety Disorders in a Canadian Population Based Study".
     Headache. 2017;57:500-501.
     PubMed     Text format    
     
     
     
236. BUETTNER C, Melo-Carrillo A, Burstein R
     Terminating Migraine-Associated Allodynia Using Oral Suspension Diclofenac: A Prospective Non-Randomized Drug Trial.
     Headache. 2017;57:478-486.
     PubMed     Text format    
     
     
     February 2017
237. ORR SL, Ramsay T, Christie SN, Dodick D, et al
     The Non-Inferiority Margins in Migraine Research (NIMM) Survey.
     Headache. 2017 Feb 11. doi: 10.1111/head.13048.
     PubMed     Text format     Abstract available
     
     
     
238. LIPTON RB, Buse DC, Adams AM, Varon SF, et al
     Family Impact of Migraine: Development of the Impact of Migraine on Partners and Adolescent Children (IMPAC) Scale.
     Headache. 2017 Feb 10. doi: 10.1111/head.13028.
     PubMed     Text format     Abstract available
     
     
     
239. FRIEDMAN DI, Evans RW
     Are Blurred Vision and Short-Duration Visual Phenomena Migraine Aura Symptoms?
     Headache. 2017 Feb 9. doi: 10.1111/head.13042.
     PubMed     Text format    
     
     
     
240. SHABAS D, Sheikh HU, Gilad R
     Pituitary Apoplexy Presenting as Status Migrainosus.
     Headache. 2017 Feb 9. doi: 10.1111/head.13046.
     PubMed     Text format    
     
     
     
241. TIETJEN GE, Collins SA
     Hypercoagulability and Migraine.
     Headache. 2017 Feb 9. doi: 10.1111/head.13044.
     PubMed     Text format     Abstract available
     
     
     
242. AUPIAIS C, Wanin S, Romanello S, Spiri D, et al
     Association Between Migraine and Atopic Diseases in Childhood: A Potential Protective Role of Anti-Allergic Drugs.
     Headache. 2017 Feb 4. doi: 10.1111/head.13032.
     PubMed     Text format     Abstract available
     
     
     
243. KRASENBAUM LJ
     A Review of "Hormonal Contraceptives and Migraine With Aura - Is There Still a Risk?"
     Headache. 2017;57:313.
     PubMed     Text format    
     
     
     
244. POWERS SW, Hershey AD, Coffey CS
     The Childhood and Adolescent Migraine Prevention (CHAMP) Study: "What Do We Do Now?"
     Headache. 2017;57:180-183.
     PubMed     Text format    
     
     
     
245. BLUMENTHAL H
     An American Headache Doctor in Beijing.
     Headache. 2017;57:309-312.
     PubMed     Text format    
     
     
     January 2017
246. SENG EK, Buse DC, Klepper JE, J Mayson S, et al
     Psychological Factors Associated With Chronic Migraine and Severe Migraine-Related Disability: An Observational Study in a Tertiary Headache Center.
     Headache. 2017 Jan 31. doi: 10.1111/head.13021.
     PubMed     Text format     Abstract available
     
     
     
247. ORDAS CM, Torres-Gaona G, Pardo-Moreno J, Cuadrado ML, et al
     Case Report: Prolonged Dysphonia During Migraine Attacks.
     Headache. 2017 Jan 30. doi: 10.1111/head.13026.
     PubMed     Text format    
     
     
     
248. ROBBINS NM, Bernat JL
     Minority Representation in Migraine Treatment Trials.
     Headache. 2017 Jan 27. doi: 10.1111/head.13018.
     PubMed     Text format     Abstract available
     
     
     
249. GROSSMAN TB, Govindappagari S, Dayal AK, Robbins MS, et al
     Delivery Outcomes of Patients with Acute Migraine in Pregnancy: A Retrospective Study.
     Headache. 2017 Jan 18. doi: 10.1111/head.13023.
     PubMed     Text format     Abstract available
     
     
     
250. TARANTINO S, De Ranieri C, Dionisi C, Gagliardi V, et al
     Role of the Attachment Style in Determining the Association Between Headache Features and Psychological Symptoms in Migraine Children and Adolescents. An Analytical Observational Case-Control Study.
     Headache. 2017 Jan 6. doi: 10.1111/head.13007.
     PubMed     Text format     Abstract available
     
     
     December 2016
251. NG QX, Venkatanarayanan N, Kumar L
     A Systematic Review and Meta-Analysis of the Efficacy of Cognitive Behavioral Therapy for the Management of Pediatric Migraine.
     Headache. 2016 Dec 28. doi: 10.1111/head.13016.
     PubMed     Text format     Abstract available
     
     
     
252. NEEB L, Bastian K, Villringer K, Israel H, et al
     Structural Gray Matter Alterations in Chronic Migraine: Implications for a Progressive Disease?
     Headache. 2016 Dec 28. doi: 10.1111/head.13012.
     PubMed     Text format     Abstract available
     
     
     
253. BOND DS, Pavlovic JM, Lipton RB, Graham Thomas J, et al
     Sexual Dysfunction in Women With Migraine and Overweight/Obesity: Relative Frequency and Association With Migraine Severity.
     Headache. 2016 Dec 28. doi: 10.1111/head.13019.
     PubMed     Text format     Abstract available
     
     
     
254. BARKER AT, Shields K
     Transcranial Magnetic Stimulation: Basic Principles and Clinical Applications in Migraine.
     Headache. 2016 Dec 28. doi: 10.1111/head.13002.
     PubMed     Text format     Abstract available
     
     
     
255. CARVALHO GF, Bonato P, Florencio LL, Pinheiro CF, et al
     Balance Impairments in Different Subgroups of Patients With Migraine.
     Headache. 2016 Dec 19. doi: 10.1111/head.13009.
     PubMed     Text format     Abstract available
     
     
     
256. FULLER-THOMSON E, Jayanthikumar J, Agbeyaka SK
     Untangling the Association Between Migraine, Pain, and Anxiety: Examining Migraine and Generalized Anxiety Disorders in a Canadian Population Based Study.
     Headache. 2016 Dec 19. doi: 10.1111/head.13010.
     PubMed     Text format     Abstract available
     
     
     
257. TIETJEN GE, Karmakar M, Amialchuk AA
     Emotional Abuse History and Migraine Among Young Adults: A Retrospective Cross-Sectional Analysis of the Add Health Dataset.
     Headache. 2016 Dec 5. doi: 10.1111/head.12994.
     PubMed     Text format     Abstract available
     
     
     
258. AURORA SK, Brin MF
     Chronic Migraine: An Update on Physiology, Imaging, and the Mechanism of Action of Two Available Pharmacologic Therapies.
     Headache. 2016 Dec 2. doi: 10.1111/head.12999.
     PubMed     Text format     Abstract available
     
     
     
259. KATO Y, Hayashi T, Kobayashi T, Masuoka A, et al
     De Novo Migraine With Aura After Surgical Repair of Aortic Coarctation.
     Headache. 2016 Dec 2. doi: 10.1111/head.12995.
     PubMed     Text format     Abstract available
     
     
     
260. LIU IY, Ishiyama A, Sepahdari AR, Johnson K, et al
     Bilateral Endolymphatic Hydrops in a Patient With Migraine Variant Without Vertigo: A Case Report.
     Headache. 2016 Dec 2. doi: 10.1111/head.12976.
     PubMed     Text format     Abstract available
     
     
     
261. MAASUMI K, Tepper SJ, Kriegler JS
     Menstrual Migraine and Treatment Options: Review.
     Headache. 2016 Dec 2. doi: 10.1111/head.12978.
     PubMed     Text format     Abstract available
     
     
     November 2016
262. SILBERSTEIN SD
     Topiramate in Migraine Prevention: A 2016 Perspective.
     Headache. 2016 Nov 30. doi: 10.1111/head.12997.
     PubMed     Text format     Abstract available
     
     
     
263. RHEE TG, Harris IM
     Gender Differences in the Use of Complementary and Alternative Medicine and Their Association With Moderate Mental Distress in U.S. Adults With Migraines/Severe Headaches.
     Headache. 2016 Nov 25. doi: 10.1111/head.12986.
     PubMed     Text format     Abstract available
     
     
     
264. BARON J, Ruiz M, Palacios-Cena M, Madeleine P, et al
     Differences in Topographical Pressure Pain Sensitivity Maps of the Scalp Between Patients With Migraine and Healthy Controls.
     Headache. 2016 Nov 25. doi: 10.1111/head.12984.
     PubMed     Text format     Abstract available
     
     
     
265. RAGGI A, Giovannetti AM, Leonardi M, Sansone E, et al
     Predictors of 12-Months Relapse After Withdrawal Treatment in Hospitalized Patients With Chronic Migraine Associated With Medication Overuse: A Longitudinal Observational Study.
     Headache. 2016 Nov 14. doi: 10.1111/head.12979.
     PubMed     Text format     Abstract available
     
     
     
266. BUSE DC, Reed ML, Fanning KM, Kurth T, et al
     Cardiovascular Events, Conditions, and Procedures Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study.
     Headache. 2016 Nov 12. doi: 10.1111/head.12962.
     PubMed     Text format     Abstract available
     
     
     
267. TAGA A, Russo M, Manzoni GC, Torelli P, et al
     Cluster Headache With Accompanying Migraine-Like Features: A Possible Clinical Phenotype.
     Headache. 2016 Nov 10. doi: 10.1111/head.12971.
     PubMed     Text format     Abstract available
     
     
     
268. FERREIRA KS, Guilherme G, Faria VR, Borges LM, et al
     Women Living Together Have a Higher Frequency of Menstrual Migraine.
     Headache. 2016 Nov 10. doi: 10.1111/head.12969.
     PubMed     Text format     Abstract available
     
     
     
269. SHIRAHIGE L, Melo L, Nogueira F, Rocha S, et al
     Efficacy of Noninvasive Brain Stimulation on Pain Control in Migraine Patients: A Systematic Review and Meta-Analysis.
     Headache. 2016;56:1565-1596.
     PubMed     Text format     Abstract available
     
     
     
270. MAINARDI F, Zanchin G, Maggioni F
     Olfactory Aura: A Missing Tool?
     Headache. 2016;56:1670.
     PubMed     Text format    
     
     
     October 2016
271. KOWACS F, Ferreira Gomes M, Pigozzo T, Rodrigues Palmeira AL, et al
     Migraine-Like Headache as Presentation Symptom in Susac Syndrome.
     Headache. 2016 Oct 26. doi: 10.1111/head.12991.
     PubMed     Text format    
     
     
     
272. FORNAZIERI MA, Neto AR, de Rezende Pinna F, Gobbi Porto FH, et al
     Olfactory symptoms reported by migraineurs with and without auras.
     Headache. 2016 Oct 25. doi: 10.1111/head.12973.
     PubMed     Text format     Abstract available
     
     
     
273. CALHOUN AH
     Hormonal Contraceptives and Migraine With Aura-Is There Still a Risk?
     Headache. 2016 Oct 24. doi: 10.1111/head.12960.
     PubMed     Text format     Abstract available
     
     
     
274. ABKUR TM, Omer E, Saeed M
     A case of stroke-like migraine attacks after radiation therapy.
     Headache. 2016 Oct 20. doi: 10.1111/head.12967.
     PubMed     Text format    
     
     
     
275. LIPTON RB, Munjal S, Buse DC, Fanning KM, et al
     Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
     Headache. 2016 Oct 12. doi: 10.1111/head.12941.
     PubMed     Text format     Abstract available
     
     
     
276. PATEL T, Elphick A, Jackson JE, Shovlin CL, et al
     Injections of Intravenous Contrast for Computerized Tomography Scans Precipitate Migraines in Hereditary Hemorrhagic Telangiectasia Subjects at Risk of Paradoxical Emboli: Implications for Right-to-Left Shunt Risks.
     Headache. 2016 Oct 11. doi: 10.1111/head.12963.
     PubMed     Text format     Abstract available
     
     
     
277. SCHANKIN CJ, Viana M, Goadsby PJ
     Persistent and Repetitive Visual Disturbances in Migraine: A Review.
     Headache. 2016 Oct 7. doi: 10.1111/head.12946.
     PubMed     Text format     Abstract available
     
     
     
278. CALHOUN AH, Gill N
     Presenting a New, Non-Hormonally Mediated Cyclic Headache in Women: End-Menstrual Migraine.
     Headache. 2016 Oct 5. doi: 10.1111/head.12942.
     PubMed     Text format     Abstract available
     
     
     
279. JUSTUSSON E, Han DD, Kapoor S, Smith JH, et al
     Odorant-Triggered Migraine Attacks in a Case of Iatrogenic Olfactory Neuropathy.
     Headache. 2016;56:1512-1513.
     PubMed     Text format    
     
     
     September 2016
280. SCHULTE LH, May A
     Functional Neuroimaging in Migraine: Chances and Challenges.
     Headache. 2016 Sep 22. doi: 10.1111/head.12944.
     PubMed     Text format     Abstract available
     
     
     
281. CERNUDA-MOROLLON E, Riesco N, Martinez-Camblor P, Serrano-Pertierra E, et al
     No Change in Interictal PACAP Levels in Peripheral Blood in Women With Chronic Migraine.
     Headache. 2016 Sep 16. doi: 10.1111/head.12949.
     PubMed     Text format     Abstract available
     
     
     
282. DUSSOR G, Cao YQ
     TRPM8 and Migraine.
     Headache. 2016 Sep 16. doi: 10.1111/head.12948.
     PubMed     Text format     Abstract available
     
     
     
283. VURALLI D, Evren Boran H, Cengiz B, Coskun O, et al
     Chronic Migraine Is Associated With Sustained Elevation of Somatosensory Temporal Discrimination Thresholds.
     Headache. 2016 Sep 16. doi: 10.1111/head.12947.
     PubMed     Text format     Abstract available
     
     
     
284. LARROSA D, Ramon C, Alvarez R, Martinez-Camblor P, et al
     No Relationship Between Patent Foramen Ovale and Migraine Frequency.
     Headache. 2016 Sep 16. doi: 10.1111/head.12945.
     PubMed     Text format     Abstract available
     
     
     
285. MUNJAL S, Gautam A, Offman E, Brand-Schieber E, et al
     A Randomized Trial Comparing the Pharmacokinetics, Safety, and Tolerability of DFN-02, an Intranasal Sumatriptan Spray Containing a Permeation Enhancer, With Intranasal and Subcutaneous Sumatriptan in Healthy Adults.
     Headache. 2016 Sep 10. doi: 10.1111/head.12905.
     PubMed     Text format     Abstract available
     
     
     June 2016
286. KEMPNER J
     What Biology Can't Do.
     Headache. 2016;56:1047-52.
     PubMed     Text format    
     
     
     
287. GIL-GOUVEIA R, Oliveira AG, Pavao Martins I
     Clinical Utility of the Mig-SCog.
     Headache. 2016;56:941-51.
     PubMed     Text format     Abstract available
     
     
     March 2016
288. DONNET A, Braunstein D, Pradel V, Sciortino V, et al
     Ergot Use and Overuse: A Pharmacoepidemiology Retrospective Cohort Study.
     Headache. 2016;56:547-54.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Migraine is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: